Moderna, Inc. vs Orgenesis Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Moderna, Inc. is the larger company by market value: $90.1 B against $15 M for Orgenesis Inc., 6009 times as much (market caps of Oct 30, 2026 for Moderna, Inc. and Jan 5, 2024 for Orgenesis Inc.). Orgenesis Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
- Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $8 M for Orgenesis Inc.
- Orgenesis Inc. made a net profit of $6 M, while Moderna, Inc. made a net loss of $2.8 B.
- Orgenesis Inc. keeps more of each dollar of sales: a net margin of 81.6% against -145.2% for Moderna, Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Moderna, Inc. MRNA · #275 in the world | Orgenesis Inc. ORGS |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | 2010 | — |
| Size | ||
| Market cap | $90.1 B | $15 M* |
| Revenue | $1.9 B | $8 M |
| Net income | $-2.8 B | $6 M▲ best |
| Employees | 4,700 | — |
| Valuation | ||
| Price to sales | 35.7× | — |
| Price to book | 10.4× | — |
| Free cash flow yield | -2.3% | — |
| Profitability | ||
| Gross margin | 55.4% | — |
| Operating margin | -158.1% | — |
| Net margin | -145.2% | — |
| Return on equity | -28.9% | — |
| Growth | ||
| Revenue growth | -39.9% | — |
| Revenue growth, 3 years a year | -53.4% | — |
| Financial strength | ||
| Debt to equity | 0.1× | — |
| Cash | ||
| Free cash flow margin | -106.2% | — |
| Shareholder returns | ||
| Shareholder yield | 0.0% | — |
| Strength scores | ||
| Piotroski F-score | 3 of 9 | — |
| Altman Z-score zone | safe | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Jan 2024 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Moderna, Inc. or Orgenesis Inc.?
Moderna, Inc. is the larger company by market value: $90.1 B against $15 M for Orgenesis Inc., 6009 times as much (market caps of Oct 30, 2026 for Moderna, Inc. and Jan 5, 2024 for Orgenesis Inc.). Orgenesis Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
Which makes more money, Moderna, Inc. or Orgenesis Inc.?
Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $8 M for Orgenesis Inc. Orgenesis Inc. made a net profit of $6 M, while Moderna, Inc. made a net loss of $2.8 B.
Which is more profitable, Moderna, Inc. or Orgenesis Inc.?
Orgenesis Inc. keeps more of each dollar of sales: a net margin of 81.6% against -145.2% for Moderna, Inc.
More about Moderna, Inc.
More about Orgenesis Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.